1. Companies

  2. Daiichi Sankyo

Daiichi Sankyo

Daiichi Sankyo

Global pharmaceutical company with a rich legacy of innovation to help patients. See our community guidelines: http://t.co/qlLpvGG2xS.
Launch date
Employees
501-1000 people
Market cap
$75.2b
Enterprise valuation
$66.5b (Public information from Sep 2024)
Tokyo Japan (HQ)
http://daiichisankyo.com
https://twitter.com/daiichisankyohttps://www.linkedin.com/company/daiichi-sankyo-co-ltd-/

Financials

Estimates*

Edit
Revenues, earnings & profits over time
JPY2021202220232024202520262027
Revenues962.5b1.0t1.3t1.6t1.8t2.1t2.5t
% growth(2 %)9 %22 %25 %13 %16 %17 %
EBITDA134.3b137.5b203.1b302.9b307.4b378.0b503.1b
% EBITDA margin14 %13 %16 %19 %17 %18 %20 %
Profit76.0b67.0b109.2b200.7b208.7b263.6b364.7b
% profit margin8 %6 %9 %13 %11 %13 %15 %
EV / revenue5.8x4.3x7.0x5.4x5.9x5.1x4.3x
EV / EBITDA41.3x32.4x44.3x28.4x35.1x28.4x21.3x
R&D budget227.4b260.2b341.6b365.2b---
R&D % of revenue24 %25 %27 %23 %---

Source: Dealroom estimates

    • Edit
DateInvestorsAmountRound
N/A

N/A

IPO
Total Funding-

Related Content

Recent News about Daiichi Sankyo

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
    • Edit
SymBio Pharmaceuticals
SymBio Pharmaceuticals
exited
Plexxikon
Plexxikon
ACQUISITION by Daiichi Sankyo Feb 2011
Ambit Biosciences
Ambit Biosciences
ACQUISITION by Daiichi Sankyo Sep 2014
Coherus Biosciences
Coherus Biosciences
exited
Charleston Laboratories
Charleston Laboratories
U3 Pharma
U3 Pharma
ACQUISITION by Daiichi Sankyo May 2008
Im
Im
ACQUISITION by Daiichi Sankyo Oct 2015
Cuorips
Cuorips
exited
Daiichi Sankyo UK Ltd.
Daiichi Sankyo UK Ltd.
ACQUISITION by Daiichi Sankyo Apr 2006
Daiichi Sankyo Espha
Daiichi Sankyo Espha
ACQUISITION by Qol Holdings Oct 2023